Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Alnylam and Collaborators Publish New Pre-clinical Results with an RNAi ... 

 

Alnylam and Collaborators Publish New Pre-clinical Results with an RNAi ...
MarketWatch (press release)
This increase in erythropoietin was detectable out to two weeks after administration of a single dose of the RNAi therapeutic and was associated with a sustained increased in red blood cell parameters including reticulocyte count, hemoglobin and ...

 

Posted on 13-Jun-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: